Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS
Clinical trial NCT02706899 · TERMINATED
Trial details
- NCT number
- NCT02706899
- Sponsor
- Seagen Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-11-06
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.